These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1047 related articles for article (PubMed ID: 29502284)
1. Fertility preservation for female cancer patients. Harada M; Osuga Y Int J Clin Oncol; 2019 Jan; 24(1):28-33. PubMed ID: 29502284 [TBL] [Abstract][Full Text] [Related]
2. [Fertility preservation in adolescents and young adults with cancer]. Rousset-Jablonski C; Chevillon F; Dhedin N; Poirot C Bull Cancer; 2016 Dec; 103(12):1019-1034. PubMed ID: 27817861 [TBL] [Abstract][Full Text] [Related]
3. Fertility preservation options in breast cancer patients. Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157 [TBL] [Abstract][Full Text] [Related]
4. Fertility sparing in cancer patients. Bouchlariotou S; Tsikouras P; Benjamin R; Neulen J Minim Invasive Ther Allied Technol; 2012 Jul; 21(4):282-92. PubMed ID: 21919808 [TBL] [Abstract][Full Text] [Related]
5. A Real-Life Analysis of Reproductive Outcome after Fertility Preservation in Female Cancer Patients. Hulsbosch S; Koskas M; Tomassetti C; De Sutter P; Wildiers H; Neven P; D'Hooghe T; Amant F Gynecol Obstet Invest; 2018; 83(2):156-163. PubMed ID: 29050014 [TBL] [Abstract][Full Text] [Related]
6. Where are oncofertility and fertility preservation treatments heading in 2016? Harada M; Osuga Y Future Oncol; 2016 Oct; 12(20):2313-21. PubMed ID: 27328888 [TBL] [Abstract][Full Text] [Related]
7. [Possibilities of cryopreservation of ovarian tissue for fertility preservation in cancer patients]. Gamzatoval ZKh; Komlichenko EV; Kostareva AA; Galagudza MM; Berlev IV; Urmancheeva AF; Ulrikh EA; Malashicheva AB; Belyakova MV; Molotkova MY Vopr Onkol; 2015; 61(2):199-204. PubMed ID: 26087598 [TBL] [Abstract][Full Text] [Related]
8. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in fertility preservation and counseling for female cancer patients. Dolmans MM Expert Rev Anticancer Ther; 2018 Feb; 18(2):115-120. PubMed ID: 29220203 [TBL] [Abstract][Full Text] [Related]
10. Fertility preservation in pediatric, adolescent and young adult female cancer patients. Ayensu-Coker L; Bauman D; Lindheim SR; Breech L Pediatr Endocrinol Rev; 2012 Nov; 10(1):174-87. PubMed ID: 23469394 [TBL] [Abstract][Full Text] [Related]
11. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER. Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337 [TBL] [Abstract][Full Text] [Related]
12. The unmet need for oncofertility preservation in women: Results of a survey by different oncological specialists in Lazio, Italy. Fabi A; Lanzetta G; Vizza E; Corsi D; Moscetti L; Spinelli G; Mentuccia L; Lalle M; Perrone M; Baiocco L; Falcicchio C; Milani A; Giannarelli D; Cognetti F; Pugliese P Curr Probl Cancer; 2019 Dec; 43(6):100479. PubMed ID: 31126661 [TBL] [Abstract][Full Text] [Related]
13. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up. Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910 [TBL] [Abstract][Full Text] [Related]
14. Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline. Dolmans MM; Donnez J Minerva Ginecol; 2018 Aug; 70(4):402-407. PubMed ID: 29644332 [TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation. Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552 [TBL] [Abstract][Full Text] [Related]
16. Strategies for fertility preservation in young early breast cancer patients. Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638 [TBL] [Abstract][Full Text] [Related]
18. Current and Future Perspectives for Improving Ovarian Tissue Cryopreservation and Transplantation Outcomes for Cancer Patients. Lee S; Ozkavukcu S; Ku SY Reprod Sci; 2021 Jun; 28(6):1746-1758. PubMed ID: 33791995 [TBL] [Abstract][Full Text] [Related]
19. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Martinez F Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320 [TBL] [Abstract][Full Text] [Related]
20. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Martinez F; Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]